Treatment of agitation after cardiac surgery with dexmedetomidine

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N52

Enrollment

200

Registered

2024-09-28

Start date

2022-07-19

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation. Restlessness and agitation

Interventions

Intervention 1: Intervention group: In the dexmedetomidine group (100 people), the infusion of dexmedetomidine drug (from a solution of 4 units per ml) was performed at the rate of 0.5 mic/kg/hour for

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Elective heart surgery candidate Consent to participate in the study

Exclusion criteria

Exclusion criteria: Existence of underlying non-cardiac disease (kidney, lung, liver, neurological, etc.) Severe brain injury during surgery Admission to ICU with open sternum

Design outcomes

Primary

Measure	Time frame
Agitation. Timepoint: From the beginning of the intervention for 48 hours and once every three hours. Method of measurement: Ramsay sedation score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEisa Bilejani

Tabriz University of Medical Sciences

Mkhanbabayi@yahoo.com+98 41 3335 7310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026